carvedilol has been researched along with ascorbic acid in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hinz, S; Karcz, T; Kieć-Kononowicz, K; Kubas, B; Kuder, K; Latacz, G; Müller, CE; Olejarz-Maciej, A; Schabikowski, J; Schlenk, M; Synak, D; Załuski, M; Zygmunt, M | 1 |
| Fyhrquist, F; Metsärinne, K; Saijonmaa, O | 1 |
| Bassenge, E; Fink, B; Fink, N; Schwemmer, M | 1 |
| Maehara, K; Maruyama, Y; Sakabe, A; Yaoita, H | 1 |
| Budni, P; Dalmarco, EM; Dalmarco, JB; Frode, TS; Pedrosa, RC; Wilhelm Filho, D | 1 |
| El-Desoky, K; El-Shitany, NA | 1 |
1 review(s) available for carvedilol and ascorbic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for carvedilol and ascorbic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Novel multi-target directed ligands based on annelated xanthine scaffold with aromatic substituents acting on adenosine receptor and monoamine oxidase B. Synthesis, in vitro and in silico studies.
Topics: Adenosine A2 Receptor Antagonists; Dose-Response Relationship, Drug; Humans; Ligands; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Receptor, Adenosine A2A; Structure-Activity Relationship; Xanthine | 2019 |
Carvedilol and its metabolites suppress endothelin-1 production in human endothelial cell culture.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Ascorbic Acid; Calcium Channel Blockers; Carbazoles; Carvedilol; Cells, Cultured; Endothelin-1; Endothelium, Vascular; Humans; Metoprolol; Nicardipine; Prazosin; Probucol; Propanolamines; Propranolol; Umbilical Veins | 1997 |
Tolerance to nitrates with enhanced radical formation suppressed by carvedilol.
Topics: Adrenergic beta-Antagonists; Animals; Antioxidants; Ascorbic Acid; Blood Platelets; Calcium; Carbazoles; Carvedilol; Cyclic GMP; Dogs; Female; Male; Nitroglycerin; Nitroprusside; Platelet Aggregation; Propanolamines; Reactive Oxygen Species; Vasodilator Agents | 1999 |
Different effects of carvedilol, metoprolol, and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Ascorbic Acid; Carbazoles; Cardiac Catheterization; Carvedilol; Coronary Disease; Coronary Stenosis; Disease Models, Animal; Dose-Response Relationship, Drug; Echocardiography; Hemodynamics; Male; Metoprolol; Norepinephrine; Propanolamines; Propranolol; Quinazolines; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Stroke Volume; Survival Rate; Thiobarbituric Acid Reactive Substances; Ventricular Function, Left; Ventricular Remodeling | 2002 |
Carvedilol enhances the antioxidant effect of vitamins E and C in chronic Chagas heart disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Antioxidants; Ascorbic Acid; Biomarkers; Carbazoles; Carvedilol; Chagas Disease; Chronic Disease; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Oxidative Stress; Propanolamines; Prospective Studies; Time Factors; Treatment Outcome; Vitamin E; Young Adult | 2013 |
Protective Effects of Carvedilol and Vitamin C against Azithromycin-Induced Cardiotoxicity in Rats via Decreasing ROS, IL1-β, and TNF-α Production and Inhibiting NF-κB and Caspase-3 Expression.
Topics: Animals; Anti-Bacterial Agents; Ascorbic Acid; Azithromycin; Carbazoles; Cardiotoxicity; Carvedilol; Caspase 3; Electrocardiography; Interleukin-1beta; Male; NF-kappa B; Propanolamines; Random Allocation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 2016 |